The provider administers a meningococcal recombinant protein and outer membrane vesicle vaccine to prevent the patient from getting a meningococcal disease such as Neisseria meningitides, as part of a two–dose schedule intramuscularly. The vaccine is recommended for individuals 10 years old and older at risk for the disease.
For clinical responsibility, terminology, tips and additional info
start codify free trial.